Advertisement

Topics

Oragenics, Inc. Regains Compliance with NYSE American Continued Listing Standards

07:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Florida-based biopharmaceutical company Oragenics, Inc. (NYSE American: OGEN) (the “Company”) today announced receipt of notification from the NYSE American LLC (the “Exchange”) that the Company has regained compliance...

Other Sources for this Article

Oragenics, Inc.
Corporate:
Michael Sullivan, 813-286-7900
Chief Financial Officer
msullivan@oragenics.com
or
Investor/Media Relations:
The Ruth Group
Tram Bui, 646-536-7035
tbui@theruthgroup.com

NEXT ARTICLE

More From BioPortfolio on "Oragenics, Inc. Regains Compliance with NYSE American Continued Listing Standards"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...